Abstract
Studies of the role of macrophages in phagocytosis are of great theoretical and practical importance for understanding how these cells are involved in the organism’s defense response and in the development of various pathologies. Here we investigated phagocytic plasticity of THP–1 (acute monocytic human leukemia) cells at different stages (days 1, 3, and 7) of phorbol ester (PMA)–induced macrophage differentiation. Analysis of cytokine profiles showed that PMA at a concentration of 100 nM induced development of the proinflammatory macrophage population. The functional activity of macrophages was assessed on days 3 and 7 of differentiation using unlabeled latex beads and latex beads conjugated with ligands (gelatin, mannan, and IgG Fc fragment) that bind to the corresponding specific receptors. The general phagocytic activity increased significantly (1.5–2.0–fold) in the course of differentiation; phagocytosis occurred mostly through the Fc receptors, as shown previously for M1 macrophages. On day 7, the levels of phagocytosis of gelatin-and Fc–covered beads were high; however, the intensity of ingestion of mannan–conjugated beads via mannose receptors increased 2.5–3.0–fold as well, which indicated formation of cells with an alternative phenotype similar to that of M2 macrophages. Thus, the type and the plasticity of phagocytic activity at certain stages of macrophage differentiation can be associated with the formation of functionally mature morphological phenotype. This allows macrophages to exhibit their phagocytic potential in response to specific ligands. These data are of fundamental importance and can be used to develop therapeutic methods for correcting the M1/M2 macrophage ratio in an organism.
Similar content being viewed by others
Abbreviations
- AP cells:
-
actively phagocytizing cells
- CCL:
-
chemokine
- DAPI:
-
4,6–diamidino–2–phenylindole hydrochloride
- FcR:
-
immunoglobulin G receptor
- Gel:
-
gelatin
- IgG:
-
immunoglobulin G
- IL:
-
interleukin
- Man:
-
mannan
- ManR:
-
mannose receptor
- MCP1:
-
monocyte chemoattractant protein 1
- PBS:
-
phosphate buffered saline
- PI:
-
phagocytic index
- PMA:
-
phorbol 12–myristate 13–acetate (phorbol ester)
- PN:
-
phagocytic number (average number of beads in the cytoplasm)
- RT–PCR:
-
reverse transcription polymerase chain reaction
- THP–1:
-
human acute monocytic leukemia cell line
References
Flannagan, R. S., Jaumouille, V., and Grinstein, S. (2012) The cell biology of phagocytosis, Annu. Rev. Pathol. Mech. Dis., 7, 61–98.
Hoffmann, E., Marion, S., Mishra, B. B., John, M., Kratzke, R., Ahmad, S. F., Holzer, D., Anand, P. K., Weiss, D. G., Griffiths, G., and Kuznetsov, S. A. (2010) Initial receptor–ligand interactions modulate gene expression and phagosomal properties during both early and late stages of phagocytosis, Eur. J. Cell Biol., 89, 693–704.
Taylor, P. R., Martinez–Pomares, L., Stacey, M., Lin, H–H., Brown, G. D., and Gordon, S. (2005) Macrophage receptors and immune recognition, Annu. Rev. Immunol., 23, 901–944.
Tessa, A. M., Meyaard, St., and Meyaard, L. (2011) Immune inhibitory receptors: essential regulators of phagocyte function, Eur. J. Immunol., 41, 575–587.
Chimini, G., and Chavrier, P. (2000) Function of Rho family proteins in actin dynamics during phagocytosis and engulfment, Nat. Cell Biol., 2, E191–E196.
Geijtenbeek, T. B., and Gringhuis, S. I. (2009) Signalling through C–type lectin receptors: shaping immune responses, Nat. Rev. Immunol., 9, 465–479.
Brown, G. D. (2006) Dectin–1: a signalling non–TLR pattern–recognition receptor, Nat. Rev. Immunol., 6, 33–43.
Fadok, V. A., Warner, M. L., Bratton, D. L., and Henson, P. (1998) CD36 is required for phagocytosis of apoptotic cells by human macrophages that use either a phosphatidylserine receptor or the vitronectin receptor (avβ3), J. Immunol., 161, 6250–6257.
Novoselov, V. V., Sazonova, M. A., Ivanova, E. A., and Orekhov, A. N. (2015) Study of the activated macrophage transcriptome, Exp. Mol. Pathol., 99, 575–580.
Gordon, S., and Martinez, F. O. (2010) Alternative activation of macrophages: mechanism and functions, Immunity, 32, 593–604.
Sica, A., and Mantovani, A. (2012) Macrophage plasticity and polarization: in vivo veritas, J. Clin. Invest., 122, 787–795.
Mosser, D. M., and Edwards, J. P. (2008) Exploring the full spectrum of macrophage activation, Nat. Rev. Immunol., 8, 958–969.
Mantovani, A., Sica, A., Sozzani, S., Allavena, P., Vecchi, A., and Locati, M. (2004) The chemokine system in diverse forms of macrophage activation and polarization, Trends Immunol., 25, 677–686.
Shishkina, V. C. (2014) Role of Pro–and Antiinflammatory M1 and M2 Macrophages in the Development of Atherosclerotic Lesions: Ph. D. Dissertation [in Russian], Moscow State University, Moscow.
Grigoryeva, O. A., Korovina, I. V., Gogia, B. Sh., and Sysoeva, V. Yu. (2014) Migration properties of adiposetissue–derived mesenchymal stromal cells cocultured with activated monocytes in vitro, Cell Tiss. Biol., 8, 359–367.
Chanput, W., Mes, J. J., and Wichers, H. J. (2014) THP–1cell line: an in vitro model for immune modulation approach, Int. Immunopharmacol., 23, 37–45.
Qin, Z. (2012) The use of THP–1 cells as a model for mimicking the function and regulation of monocytes and macrophages in the vasculature, Atherosclerosis, 221, 2–11.
Barendsen, N., Mueller, M., and Chen, B. (1990) Inhibition of TPA–induced monocytic differentiation in THP–1 human monocytic leukemic cells by staurosporine: a potent protein kinase C inhibitor, Leuk. Res., 14, 467–474.
Tsuchiya, S., Yamabe, M., Yamaguchi, Y., Kobayashi, Y., Konno, T., and Tada, K. (1980) Establishment and characterization of a human acute monocytic leukemia cell line (THP–1), Int. J. Cancer, 26, 171–176.
Auwerx, J. (1991) The human leukemia cell line, THP–1: a multifacetted model for the study of monocyte–macrophage differentiation, Experientia, 47, 22–31.
Schwende, H., Fitzke, E., Ambs, P., and Dieter, P. (1996) Differences in the state of differentiation of THP–1 cells induced by phorbol ester and 1,25–dihydroxyvitamin D3, J. Leukoc. Biol., 59, 555–561.
Mills, C. D., Kincaid, K., Alt, J. M., Heilman, M. J., and Hill, A. M. (2000) M–1/M–2 macrophages and the Th1/Th2 paradigm, J. Immunol., 164, 6166–6173.
Martinez, F. O., and Gordon, S. (2014) The M1 and M2 paradigm of macrophage activation: time for reassessment, F1000Prime Rep., 6, 12703.
Monastyrskaya, E. A., Lyamina, S. V., and Malyshev, I. Yu. (2008) M1 and M2 phenotypes of activated macrophages and their role in immune response and pathologies, Patogenez, 4, 31–39.
Genin, M., Clement, F., Fattaccioli, A., Raes, M., and Michiels, C. (2015) M1 and M2 macrophages derived from THP–1 cells differentially modulate the response of cancer cells to etoposide, BMC Cancer, 15, 577.
Stout, R. D., Watkins, S. K., and Suttles, J. (2009) Functional plasticity of macrophages: in situ reprogramming of tumorassociated macrophages, J. Leukoc. Biol., 86, 1105–1109.
Akagawa, K. S. (2002) Functional heterogeneity of colonystimulating factor induced human monocyte–derived macrophages, Int. J. Hematol., 76, 27–34.
Vogel, D. Y., Glim, J. E., Stavenuiter, A. W., Breur, M., Heijnen, P., Amor, S., Dijkstra, C. D., and Beelen, R. H. (2014) Human macrophage polarization in vitro: maturation and activation methods compared, Immunobiology, 219, 695–703.
Waldo, S. W., Li, Y., Buono, C., Zhao, B., Billings, E. M., Chang, J., and Kruth, H. S. (2008) Heterogeneity of human macrophages in culture and in atherosclerotic plaques, Am. J. Pathol., 172, 1112–1126.
Spiller, K. L., Anfang, R. R., Spiller, K. J., Ng, J., Nakazawa, K. R., Daulton, J. W., and Vunjak–Novakovic, G. (2014) The role of macrophage phenotype in vascularization of tissue engineering scaffolds, Biomaterials, 35, 4477–4488.
Park, E. K., Jung, H. S., Yang, H. I., Yoo, M. C., Kim, C., and Kim, K. S. (2007) Optimized THP–1 differentiation is required for the detection of responses to weak stimuli, Inflamm. Res., 56, 45–50.
Tjiu, J. W., Chen, J. S., Shun, C. T., Lin, S. J., Liao, Y. H., Chu, C. Y., Tsai, T. F., Chiu, H. C., Dai, Y. S., Inoue, H., Yang, P. C., Kuo, M. L., and Jee, S. H. (2009) Tumorassociated macrophage–induced invasion and angiogenesis of human basal cell carcinoma cells by cyclooxygenase–2 induction, J. Invest. Dermatol., 129, 1016–1025.
Leidi, M., Gotti, E., Bologna, L., Miranda, E., Rimoldi, M., Sica, A., Roncalli, M., Palumbo, G. A., Introna, M., and Golay, J. (2009) M2 macrophages phagocytose rituximab–opsonized leukemic targets more efficiently than M1 cells in vitro, J. Immunol., 182, 4415–4422.
He, C., and Carter, A. B. (2015) The metabolic prospective and redox regulation of macrophage polarization, J. Clin. Cell Immunol., 6, 371–387.
Canton, J. (2014) Phagosome maturation in polarized macrophages, J. Leukoc. Biol., 96, 729–738.
Canton, J., Khezri, R., Glogauer, M., and Grinstein, S. (2014) Contrasting phagosome pH regulation and maturation in human M1 and M2 macrophages, Mol. Biol. Cell, 25, 3330–3341.
George, L., Upadhyay, Sw., Ganguly, K., and Stoeger, T. (2014) Macrophage polarization in lung biology and diseases, in Lung Inflammation (Ong, K. C., ed.) InTech, pp. 29–57.
Demyanenko, N. G., Lepekha, L. N., Shmelev, E. I., Averbakh, M. M., Statsuk, T. A., and Sivokozov, I. V. (2016) Macrophages and cytokines in wash–offs from bronchi and alveolae in patients with newly diagnosed tuberculosis and recurring sarcoidosis of respiratory organs, Tuberkulez Bolezni Legkikh, 94, 59–64.
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © A. V. Kurynina, M. V. Erokhina, O. A. Makarevich, V. Yu. Sysoeva, L. N. Lepekha, S. A. Kuznetsov, G. E. Onishchenko, 2018, published in Biokhimiya, 2018, Vol. 83, No. 3, pp. 309–327.
Rights and permissions
About this article
Cite this article
Kurynina, A.V., Erokhina, M.V., Makarevich, O.A. et al. Plasticity of Human THP–1 Cell Phagocytic Activity during Macrophagic Differentiation. Biochemistry Moscow 83, 200–214 (2018). https://doi.org/10.1134/S0006297918030021
Received:
Revised:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S0006297918030021